311 related articles for article (PubMed ID: 18725458)
1. Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response.
Keserü B; Barbosa-Sicard E; Popp R; Fisslthaler B; Dietrich A; Gudermann T; Hammock BD; Falck JR; Weissmann N; Busse R; Fleming I
FASEB J; 2008 Dec; 22(12):4306-15. PubMed ID: 18725458
[TBL] [Abstract][Full Text] [Related]
2. EETs promote hypoxic pulmonary vasoconstriction via constrictor prostanoids.
Kandhi S; Zhang B; Froogh G; Qin J; Alruwaili N; Le Y; Yang YM; Hwang SH; Hammock BD; Wolin MS; Huang A; Sun D
Am J Physiol Lung Cell Mol Physiol; 2017 Aug; 313(2):L350-L359. PubMed ID: 28450284
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 epoxygenase-derived 5,6-epoxyeicosatrienoic acid relaxes pulmonary arteries in normoxia but promotes sustained pulmonary vasoconstriction in hypoxia.
Strielkov I; Krause NC; Knoepp F; Alebrahimdehkordi N; Pak O; Garcia C; Ghofrani HA; Schermuly RT; Seeger W; Grimminger F; Sommer N; Weissmann N
Acta Physiol (Oxf); 2020 Sep; 230(1):e13521. PubMed ID: 32506676
[TBL] [Abstract][Full Text] [Related]
4. EET-dependent potentiation of pulmonary arterial pressure: sex-different regulation of soluble epoxide hydrolase.
Kandhi S; Qin J; Froogh G; Jiang H; Luo M; Wolin MS; Huang A; Sun D
Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1478-86. PubMed ID: 26498250
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition.
Keserü B; Barbosa-Sicard E; Schermuly RT; Tanaka H; Hammock BD; Weissmann N; Fisslthaler B; Fleming I
Cardiovasc Res; 2010 Jan; 85(1):232-40. PubMed ID: 19679679
[TBL] [Abstract][Full Text] [Related]
6. 11,12-EET stimulates the association of BK channel α and β(1) subunits in mitochondria to induce pulmonary vasoconstriction.
Loot AE; Moneke I; Keserü B; Oelze M; Syzonenko T; Daiber A; Fleming I
PLoS One; 2012; 7(9):e46065. PubMed ID: 23029390
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 Epoxygenase-Dependent Activation of TRPV4 Channel Participates in Enhanced Serotonin-Induced Pulmonary Vasoconstriction in Chronic Hypoxic Pulmonary Hypertension.
Xia Y; Xia L; Jin Z; Jin R; Paudel O; Sham JSK
Anal Cell Pathol (Amst); 2020; 2020():8927381. PubMed ID: 32399392
[TBL] [Abstract][Full Text] [Related]
8. Soluble epoxide hydrolase deficiency or inhibition enhances murine hypoxic pulmonary vasoconstriction after lipopolysaccharide challenge.
Wepler M; Beloiartsev A; Buswell MD; Panigrahy D; Malhotra R; Buys ES; Radermacher P; Ichinose F; Bloch DB; Zapol WM
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1213-L1221. PubMed ID: 27815261
[TBL] [Abstract][Full Text] [Related]
9. Diacylglycerol regulates acute hypoxic pulmonary vasoconstriction via TRPC6.
Fuchs B; Rupp M; Ghofrani HA; Schermuly RT; Seeger W; Grimminger F; Gudermann T; Dietrich A; Weissmann N
Respir Res; 2011 Feb; 12(1):20. PubMed ID: 21294865
[TBL] [Abstract][Full Text] [Related]
10. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia.
Zhang W; Otsuka T; Sugo N; Ardeshiri A; Alhadid YK; Iliff JJ; DeBarber AE; Koop DR; Alkayed NJ
Stroke; 2008 Jul; 39(7):2073-8. PubMed ID: 18369166
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450-derived epoxyeicosatrienoic acids and pulmonary hypertension: central role of transient receptor potential C6 channels.
Loot AE; Fleming I
J Cardiovasc Pharmacol; 2011 Feb; 57(2):140-7. PubMed ID: 20588188
[TBL] [Abstract][Full Text] [Related]
12. Female-favorable attenuation of coronary myogenic constriction via reciprocal activations of epoxyeicosatrienoic acids and nitric oxide.
Froogh G; Qin J; Kandhi S; Le Y; Jiang H; Luo M; Sun D; Huang A
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1448-54. PubMed ID: 27016584
[TBL] [Abstract][Full Text] [Related]
13. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A
Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863
[TBL] [Abstract][Full Text] [Related]
14. A soluble epoxide hydrolase inhibitor--8-HUDE increases pulmonary vasoconstriction through inhibition of K(ATP) channels.
Liu Y; Zhang J; Yu L; Cao F; Rao J; Li J; Jiang C; Falck JR; Jacobs ER; Zhu D
Pulm Pharmacol Ther; 2012 Feb; 25(1):69-76. PubMed ID: 22155000
[TBL] [Abstract][Full Text] [Related]
15. Epoxyeicosatrienoic acids regulate Trp channel dependent Ca2+ signaling and hyperpolarization in endothelial cells.
Fleming I; Rueben A; Popp R; Fisslthaler B; Schrodt S; Sander A; Haendeler J; Falck JR; Morisseau C; Hammock BD; Busse R
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2612-8. PubMed ID: 17872452
[TBL] [Abstract][Full Text] [Related]
16. Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.
Gross GJ; Gauthier KM; Moore J; Falck JR; Hammock BD; Campbell WB; Nithipatikom K
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2838-44. PubMed ID: 18441205
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling.
Pokreisz P; Fleming I; Kiss L; Barbosa-Sicard E; Fisslthaler B; Falck JR; Hammock BD; Kim IH; Szelid Z; Vermeersch P; Gillijns H; Pellens M; Grimminger F; van Zonneveld AJ; Collen D; Busse R; Janssens S
Hypertension; 2006 Apr; 47(4):762-70. PubMed ID: 16505204
[TBL] [Abstract][Full Text] [Related]
18. Epoxyeicosatrienoic acids constrict isolated pressurized rabbit pulmonary arteries.
Zhu D; Bousamra M; Zeldin DC; Falck JR; Townsley M; Harder DR; Roman RJ; Jacobs ER
Am J Physiol Lung Cell Mol Physiol; 2000 Feb; 278(2):L335-43. PubMed ID: 10666118
[TBL] [Abstract][Full Text] [Related]
19. CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction.
Tabeling C; Yu H; Wang L; Ranke H; Goldenberg NM; Zabini D; Noe E; Krauszman A; Gutbier B; Yin J; Schaefer M; Arenz C; Hocke AC; Suttorp N; Proia RL; Witzenrath M; Kuebler WM
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1614-23. PubMed ID: 25829545
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling.
Merkel MJ; Liu L; Cao Z; Packwood W; Young J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H679-87. PubMed ID: 20008276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
